Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01235_DB01624_nanopub.RAvDNCAvh9HOchj5RnH9VTOSRrTHUWTqveBdDjTl9CUe4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01235_DB01624 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01235_DB01624 label "DDI between L-DOPA and Zuclopenthixol - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and levodopa, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB01235_DB01624]" assertion.
- drugbank_resource:DB01235_DB01624 identifier "drugbank_resource:DB01235_DB01624" assertion.
- drugbank_resource:DB01235_DB01624 title "DDI between L-DOPA and Zuclopenthixol - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and levodopa, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed." assertion.
- drugbank:DB01235 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01235_DB01624 assertion.
- drugbank:DB01624 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01235_DB01624 assertion.